Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
What’s at Stake: Sites Aren’t Neutral for Kids
Proposed changes to site-neutral payments would threaten children’s health care.
Oct. 08, 2026
Putting Children’s Health on the Agenda at AAP
CHA joined pediatric leaders from across the country to advance shared priorities and keep children’s unique health needs at the center of national conversations.
Oct. 07, 2026
New Poll Shows Strong Bipartisan Support for Children’s Health
Parents are united on key policy priorities for pediatric health care.
Oct. 05, 2026
